Optogenetic Peripheral Nerve Immunogenicity

Optogenetic technologies have been the subject of great excitement within the scientific community for their ability to demystify complex neurophysiological pathways in the central (CNS) and peripheral nervous systems (PNS). The excitement surrounding optogenetics has also extended to the clinic with a trial for ChR2 in the treatment of retinitis pigmentosa currently underway and additional trials anticipated for the near future. In this work, we identify the cause of loss-of-expression in response to transdermal illumination of an optogenetically active peroneal nerve following an anterior compartment (AC) injection of AAV6-hSyn-ChR2(H134R) with and without a fluorescent reporter. Using Sprague Dawley Rag2−/− rats and appropriate controls, we discover optogenetic loss-of-expression is chiefly elicited by ChR2-mediated immunogenicity in the spinal cord, resulting in both CNS motor neuron death and ipsilateral muscle atrophy in both low and high Adeno-Associated Virus (AAV) dosages. We further employ pharmacological immunosuppression using a slow-release tacrolimus pellet to demonstrate sustained transdermal optogenetic expression up to 12 weeks. These results suggest that all dosages of AAV-mediated optogenetic expression within the PNS may be unsafe. Clinical optogenetics for both PNS and CNS applications should take extreme caution when employing opsins to treat disease and may require concurrent immunosuppression. Future work in optogenetics should focus on designing opsins with lesser immunogenicity.

[1]  D. Jezova,et al.  The blood–spinal cord barrier: Morphology and Clinical Implications , 2011, Annals of neurology.

[2]  A. Salvetti,et al.  Improved Immunological Tolerance Following Combination Therapy with CTLA-4/Ig and AAV-Mediated PD-L1/2 Muscle Gene Transfer , 2011, Front. Microbio..

[3]  R. Glickman,et al.  Phototoxicity to the Retina: Mechanisms of Damage , 2002, International journal of toxicology.

[4]  D. Kohn,et al.  Immune response to green fluorescent protein: implications for gene therapy , 1999, Gene Therapy.

[5]  V. Preedy,et al.  Mechanisms of damage , 2002 .

[6]  James M. Wilson,et al.  Recombinant adeno-associated virus for muscle directed gene therapy , 1997, Nature Medicine.

[7]  F. Rypáček,et al.  Effective long-term immunosuppression in rats by subcutaneously implanted sustained-release tacrolimus pellet: Effect on spinally grafted human neural precursor survival , 2013, Experimental Neurology.

[8]  Hideyuki Okano,et al.  A new minimally-invasive method for microinjection into the mouse spinal dorsal horn , 2015, Scientific Reports.

[9]  Dimiter Prodanov,et al.  And Then There Was Light: Perspectives of Optogenetics for Deep Brain Stimulation and Neuromodulation , 2017, Front. Neurosci..

[10]  H. Payette,et al.  Relationship between the response to influenza vaccination and the nutritional status in institutionalized elderly subjects. , 1999, The journals of gerontology. Series A, Biological sciences and medical sciences.

[11]  Y. Mu,et al.  Transgene Expression Is Associated with Copy Number and Cytomegalovirus Promoter Methylation in Transgenic Pigs , 2009, PloS one.

[12]  Stefan R. Pulver,et al.  Independent Optical Excitation of Distinct Neural Populations , 2014, Nature Methods.

[13]  S. Kleinlogel,et al.  Chronic activation of the D156A point mutant of Channelrhodopsin-2 signals apoptotic cell death: the good and the bad , 2016, Cell Death & Disease.

[14]  Edward S Boyden,et al.  Virally delivered channelrhodopsin-2 safely and effectively restores visual function in multiple mouse models of blindness. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[15]  M. Derelanko.  Determination of erythrocyte life span in F-344, Wistar, and Sprague-Dawley rats using a modification of the [3H]diisopropylfluorophosphate ([3H]DFP) method. , 1987, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[16]  J. Beard,et al.  Iron-deficient mice fail to develop autoimmune encephalomyelitis. , 2003, The Journal of nutrition.

[17]  J. Rabinowitz,et al.  Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[18]  E. Yuliwati,et al.  A Review , 2019, Current Trends and Future Developments on (Bio-) Membranes.

[19]  Fabio Benfenati,et al.  Long-term optical stimulation of channelrhodopsin-expressing neurons to study network plasticity , 2013, Front. Mol. Neurosci..

[20]  C. Larsen,et al.  Pathogen Stimulation History Impacts Donor‐Specific CD8+ T Cell Susceptibility to Costimulation/Integrin Blockade–Based Therapy , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[21]  D. Sen,et al.  Adeno‐associated virus (AAV) vectors in gene therapy: immune challenges and strategies to circumvent them , 2013, Reviews in medical virology.

[22]  Takuya Sasaki,et al.  Optogenetic Countering of Glial Acidosis Suppresses Glial Glutamate Release and Ischemic Brain Damage , 2014, Neuron.

[23]  D. Han,et al.  Association between post-transplant red cell distribution width and prognosis of kidney transplant recipients , 2017, Scientific Reports.

[24]  J. Sherley,et al.  CFP and YFP, but Not GFP, Provide Stable Fluorescent Marking of Rat Hepatic Adult Stem Cells , 2008, Journal of biomedicine & biotechnology.

[25]  Amir Mehdi. Ansari,et al.  Cellular GFP Toxicity and Immunogenicity: Potential Confounders in in Vivo Cell Tracking Experiments , 2016, Stem Cell Reviews and Reports.

[26]  F. Sánchez‐Madrid,et al.  Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrin , 1992, Nature.

[27]  S. Remington.  Fluorescent proteins: maturation, photochemistry and photophysics. , 2006, Current opinion in structural biology.

[28]  V. Fast,et al.  Electrophysiological Properties and Viability of Neonatal Rat Ventricular Myocyte Cultures with Inducible ChR2 Expression , 2017, Scientific Reports.

[29]  Jason Chung,et al.  Long-term channelrhodopsin-2 (ChR2) expression can induce abnormal axonal morphology and targeting in cerebral cortex , 2013, Front. Neural Circuits.

[30]  L. Yucetin,et al.  Effects of some hematological parameters on whole blood tacrolimus concentration measured by two immunoassay-based analytical methods. , 2005, Clinical biochemistry.

[31]  Hugh M. Herr,et al.  Spectrally distinct channelrhodopsins for two-colour optogenetic peripheral nerve stimulation , 2018, Nature Biomedical Engineering.

[32]  P. Arany,et al.  Molecular pathway of near-infrared laser phototoxicity involves ATF-4 orchestrated ER stress , 2015, Scientific Reports.

[33]  Shriya Srinivasan,et al.  Transdermal optogenetic peripheral nerve stimulation , 2017, Journal of neural engineering.

[34]  Karl Deisseroth,et al.  Improved expression of halorhodopsin for light-induced silencing of neuronal activity , 2008, Brain cell biology.

[35]  E. Whitelaw,et al.  Age-dependent silencing of globin transgenes in the mouse. , 1996, Nucleic acids research.

[36]  Jeong Wook Lee,et al.  Proteome-Level Responses of Escherichia coli to Long-Chain Fatty Acids and Use of Fatty Acid Inducible Promoter in Protein Production , 2007, Journal of biomedicine & biotechnology.

[37]  Roland W Herzog,et al.  Evading the immune response upon in vivo gene therapy with viral vectors. , 2009, Current opinion in molecular therapeutics.

[38]  Jeff W. Lichtman,et al.  Axon Branch Removal at Developing Synapses by Axosome Shedding , 2004, Neuron.

[39]  B. Trapnell,et al.  Proteasome inhibition enhances AAV-mediated transgene expression in human synoviocytes in vitro and in vivo. , 2005, Molecular Therapy.

[40]  W Haase,et al.  Effects on capacitance by overexpression of membrane proteins. , 2008, Biochemical and biophysical research communications.

[41]  J. Burrone,et al.  Surpassing light-induced cell damage in vitro with novel cell culture media , 2017, Scientific Reports.

[42]  M Tamai,et al.  Immune responses to adeno-associated virus type 2 encoding channelrhodopsin-2 in a genetically blind rat model for gene therapy , 2011, Gene Therapy.

[43]  Michael R. Hamblin,et al.  Low-Level Laser Therapy Activates NF-kB via Generation of Reactive Oxygen Species in Mouse Embryonic Fibroblasts , 2011, PloS one.

[44]  Murtaza Z Mogri,et al.  Targeting and Readout Strategies for Fast Optical Neural Control In Vitro and In Vivo , 2007, The Journal of Neuroscience.

[45]  F. Rosendaal,et al.  The good and the bad , 2015, Journal of thrombosis and haemostasis : JTH.

[46]  K. L. Montgomery,et al.  Optogenetic Control of Targeted Peripheral Axons in Freely Moving Animals , 2013, PloS one.

[47]  H. Mizukami,et al.  A histone deacetylase inhibitor enhances recombinant adeno-associated virus-mediated gene expression in tumor cells. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[48]  S. E. Barker,et al.  Long-term effect of gene therapy on Leber's congenital amaurosis. , 2015, The New England journal of medicine.

[49]  R. Samulski,et al.  Integration of adeno-associated virus (AAV) and recombinant AAV vectors. , 2004, Annual review of genetics.

[50]  Karl Deisseroth,et al.  Beyond the brain: Optogenetic control in the spinal cord and peripheral nervous system , 2016, Science Translational Medicine.

[51]  K. Deisseroth,et al.  eNpHR: a Natronomonas halorhodopsin enhanced for optogenetic applications , 2008, Brain cell biology.

[52]  S. Jacques.  Optical properties of biological tissues: a review , 2013, Physics in medicine and biology.

[53]  E. Bamberg,et al.  Channelrhodopsin-2 is a leaky proton pump , 2009, Proceedings of the National Academy of Sciences.

[54]  D. Tuan,et al.  Stable and unstable transgene integration sites in the human genome: extinction of the Green Fluorescent Protein transgene in K562 cells. , 2000, Gene.

[55]  K. High,et al.  Immune responses to AAV vectors: overcoming barriers to successful gene therapy. , 2013, Blood.

[56]  Jonghan Kim,et al.  Rapid and Efficient Clearance of Blood-borne Virus by Liver Sinusoidal Endothelium , 2011, PLoS pathogens.